Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metoclopramide to Treat Anemia in Patients With Myelodysplastic Syndrome (MDS)

NCT00120653 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT00120653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00120653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metoclopramide to Treat Anemia in Patients With Myelodysplastic Syndrome (MDS)
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Phase 2
Overall status
Withdrawn
Start date
July 14, 2005
Completion date
June 17, 2008
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic syndromes